Clinical Trial Update: Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating zoledronic acid to prevent bone loss after bariatric surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss
• Muscle Atrophy

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Stinus Gadegaard Hansen | Conditions: Bone Loss, Muscle Atrophy | Phase 2 | Status: UNKNOWN